Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03796169
Other study ID # XC15FIMI0020K
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 12, 2018
Est. completion date February 12, 2020

Study information

Verified date September 2020
Source Seoul St. Mary's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to investigate whether the personal characteristics of the endoscopist is associated with effect of interventions for colonoscopy quality improvement.

This is a prospective, 9-month, multicenter, single-blind study. Baseline quality indicators including adenoma detection rate, polyp detection rate, withdrawal time and adenomas per colonoscopy of each endoscopist were measured in the health promotion centers of academic hospitals for 3 months. Follow-up measurements of quality indicators were repeated every 3 months after each interventions (personal notification of quality indicators, open notification of quality indicators, and colonoscopy quality education by a GI faculty. At the end of the study, personal characteristics of each endoscopist was evaluated using fear of negative evaluation scale, cognitive flexibility inventory, and almost perfect scale.


Description:

Suboptimal colonoscopy quality is associated with development of interval colorectal cancer and colorectal cancer-related death. It is uncertain how to improve colonoscopy quality effectively. The quality of screening colonoscopy for colorectal cancer depends on the endoscopist who performed the examination. The aim of this study was to investigate the impact of endoscopists' personal characteristics on the quality of colonoscopy and effectiveness of intervention.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date February 12, 2020
Est. primary completion date December 12, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Highly experienced board-certified gastroenterologists performed colonoscopies in health screening endoscopy centers.

- Endoscopists who sign the consent

- Patients for quality indicators of endoscopists

- routinely perform outpatient screening, surveillance and diagnostic colonoscopy (first-time screening colonoscopies performed and had no previous colonoscopy within 3 years).

Exclusion Criteria:

- endoscopists who refuse to sign the consent

- Patients for quality indicators of endoscopists

- Known hereditary polyposis syndrome, Inflammatory bowel disease, those with surgically altered anatomy, undergone previous colonoscopy within 3 years

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Personal notification
Baseline quality indicators of each endoscopist were measured and those were notified individually.
Open notification
Quality indicators were measured for 3 months after 1st interventions and those were notified openly
Education
Quality indicators were measured for 3 months after 2nd interventions and educated the importance of colonoscopy quality by a GI faculty

Locations

Country Name City State
Korea, Republic of Division of Gastroenterology; Seoul St. Mary's hospital Seoul

Sponsors (3)

Lead Sponsor Collaborator
Seoul St. Mary's Hospital Saint Vincent's Hospital, Korea, Uijeongbu St. Mary Hospital

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (3)

Coe SG, Crook JE, Diehl NN, Wallace MB. An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol. 2013 Feb;108(2):219-26; quiz 227. doi: 10.1038/ajg.2012.417. Epub 2013 Jan 8. — View Citation

Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E; COLONPREV Study Investigators. Endoscopist characteristics that influence the quality of colonoscopy. Endoscopy. 2016 Mar;48(3):241-7. doi: 10.1055/s-0042-100185. Epub 2016 Feb 4. — View Citation

Shaukat A, Oancea C, Bond JH, Church TR, Allen JI. Variation in detection of adenomas and polyps by colonoscopy and change over time with a performance improvement program. Clin Gastroenterol Hepatol. 2009 Dec;7(12):1335-40. doi: 10.1016/j.cgh.2009.07.027. Epub 2009 Aug 7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of overall adenoma detection rate Primary outcome measures include overall adenoma detection rate. 9 months
Primary Measurement of adenoma detection rate after personal notification Primary outcome measures include adenoma detection rate after personal notification 3 months after personal notification
Primary Measurement of adenoma detection rate after open notification Primary outcome measures include adenoma detection rate after open notification 3 months after open notification
Primary Measurement of adenoma detection rate after education Primary outcome measures include adenoma detection rate after education 3 months after education
Secondary Measurement of overall polyp detection rate Secondary outcome measures include overall polyp detection rate. 9 months
Secondary Measurement of overall withdrawal time Secondary outcome measures include overall withdrawal time. 9 months
Secondary Measurement of overall adenomas per colonoscopy Secondary outcome measures include overall adenomas per colonoscopy. 9 months
Secondary Measurement of polyp detection rate after personal notification Primary outcome measures include polyp detection rate after personal notification 3 months after personal notification
Secondary Measurement of polyp detection rate after open notification Primary outcome measures include polyp detection rate after open notification 3 months after open notification
Secondary Measurement of polyp detection rate after education Primary outcome measures include polyp detection rate after education 3 months after education
Secondary Measurement of withdrawal time after personal notification Primary outcome measures include withdrawal time after personal notification 3 months after personal notification
Secondary Measurement of withdrawal time after open notification Primary outcome measures include withdrawal time after open notification 3 months after open notification
Secondary Measurement of withdrawal time after education Primary outcome measures include withdrawal time after education 3 months after education
Secondary Measurement of adenomas per colonoscopy after personal notification Primary outcome measures include adenomas per colonoscopy after personal notification. 3 months after personal notification
Secondary Measurement of adenomas per colonoscopy after open notification Primary outcome measures include adenomas per colonoscopy after open notification 3 months after open notification
Secondary Measurement of adenomas per colonoscopy after education Primary outcome measures include adenoma detection rate after education 3 months after education
See also
  Status Clinical Trial Phase
Completed NCT04101097 - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed NCT03247595 - Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy N/A
Completed NCT04214301 - An Open-Label Preference Evaluation of BLI800 Phase 4
Withdrawn NCT05754255 - Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center N/A
Recruiting NCT02484105 - Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Phase 4
Active, not recruiting NCT02264249 - Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation N/A
Terminated NCT01978509 - The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies N/A
Completed NCT01964417 - The Comparative Study Between Bowel Preparation Method Phase 3
Recruiting NCT01685970 - Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy Phase 3
Completed NCT01518790 - Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children N/A
Recruiting NCT00748293 - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet N/A
Completed NCT00779649 - MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial Phase 4
Completed NCT00671177 - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique N/A
Completed NCT00380497 - Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children Phase 4
Recruiting NCT00160823 - Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients Phase 3
Completed NCT00314418 - Patient Position and Impact on Colonoscopy Time N/A
Completed NCT00390598 - PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy Phase 2/Phase 3
Completed NCT00427089 - Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening Phase 3
Completed NCT00209573 - A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy Phase 3
Completed NCT05823350 - The Effect of Abdominal Massage on Pain and Distention After Colonoscopy N/A